Database
Funding Rounds
551 rounds tracked
Hemu Intelligent specializes in physical AI for mold manufacturing and manufacturing semantic computing, building an AI process brain for mold enterprises to automate the entire manufacturing workflow.
立昂机器人是一家专注于空间智能与具身智能的科技创新型企业,深耕具身机器人在轻工业领域的落地应用,提供空间智能控制器、具身智能控制器及行业机器人解决方案。
Lifutd
Source →Youbaote specializes in the R&D of legged bionic robots, humanoid robots, and hydraulic special robots, providing integrated solutions for intelligent robot applications.
Orient Securities Capital, Jinan Xianxing Investment Group, Zibo High-Tech Zone Venture Capital
Source →KylinWay is a national high-tech enterprise focusing on the R&D, production, and industrial application of hydrogen molecular medical new materials, providing one-stop raw material and technical solutions for cosmetics, hygiene, and medical dressing sectors.
Tiantu Capital (Beauty Leading Fund)
Source →AIPher is an AI-native drug discovery company utilizing artificial intelligence and drug foundation models like DrugCLIP to redefine innovative drug R&D.
Xianghe Capital
Source →Violoop develops a palm-sized USB device with screen-aware AI hardware that reads the user's entire screen to build a proactive AI assistant.
Medifa is a biotechnology company focused on the independent innovation, development, and scaled production of next-generation fully bio-based and naturally biodegradable PHA biomaterials and high-end downstream derivatives for industrial and medical applications.
China Taiping Insurance Group (China Taiping Innovation), Baiyun Fund
Source →Xinghui Zhongyue develops non-invasive brain-computer interface technologies and wearable BCI devices, providing auxiliary diagnosis, rehabilitation, and AI-driven EEG emotional assessment solutions for psychiatric disorders and neurological conditions.
Wuhan Venture Capital, Hongshan Capital
Source →Bangshun Pharmaceutical is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of innovative therapies for oncology and autoimmune diseases.
Kefacapital, SVIC +more
Source →Yuce Bio is an innovative enterprise focusing on precise diagnosis of neurological blood biomarkers based on single-molecule immunoassay technology, promoting clinical and health management applications.
Jiangsu Taizhou Greater Health Advanced Manufacturing Industry Special Mother Fund, Shanghai Univ-Bio, Leader Venture Capital
Source →Wavelet Intelligence is an AI for IC design innovation company that builds next-generation AI-driven EDA (Electronic Design Automation) tools and intelligent platforms to lower chip design barriers and shorten R&D cycles.
Xuanchuang Robotics is a special industrial embodied AI enterprise founded in December 2022, focusing on the R&D and application of special embodied intelligent robots for high-risk industries such as oil, chemical, and nuclear power.
Guangyang Co., Ltd., West Lake Innovation Investment
Source →VAST is an artificial intelligence company focused on 3D native intelligence, enabling users to create and run interactive, dynamically evolving 3D worlds.
Yanqu Game, Thundersoft +more
Source →Bowang Sensing specializes in the R&D and production of inductive encoders, serving as a core component supplier for industrial automation and robotics.
Dawu Venture Capital, Jiayi Venture Capital +more
Source →Haofeng Medical is a third-class interventional medical device CDMO platform company that provides global manufacturers with comprehensive services from product R&D and pre-registration production to post-market contract manufacturing.
Huayin Financial Investment
Source →Wosheng Biomedicine is an innovative biopharmaceutical company focused on next-generation protein degradation technology, dedicated to overcoming unmet clinical treatment needs in the central nervous system field.
Lilly Asia Ventures, BioTrack Capital
Source →Xianbo Biology is a clinical-stage biotechnology company focusing on next-generation cell therapy platforms including universal CAR-NK, in vivo CAR-T, and multi-targeted solid tumor CAR-T.
Futen Capital, Cenova Capital, Zhangke Herun, Yuanhe Holdings +more
Source →Xianyan Therapeutics focuses on the R&D of oligonucleotide drugs, having built proprietary core technology platforms for small nucleic acid drug delivery and interference, with pipelines targeting cardiovascular and metabolic diseases.
HighLight Capital
Source →